Back to search

Article

Vaccinia virus vaccination is expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus

2022-06-23

Abstract excerpt

<h4>ABSTRACT</h4> Starting May 2022, a novel cluster of monkeypox virus infections was detected in humans. This has spread rapidly to non-endemic countries and sparked global concern. Vaccinia virus vaccines have demonstrated high efficacy against monkeypox viruses in the past and are considered an important outbreak control measure. Viruses observed in the current outbreak carry distinct genetic variation that h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fe4b6462-34c9-5be7-be05-fb7463d66373
DOI
10.1101/2022.06.23.497143
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Vaccinia virus vaccination is expected to elicit highly cross-reactive immunity to the 2022 monkeypox virusDOI 10.1101/2022.06.23.497143
Select a neighboring publication to make it the new centre.